Lindora brings L-Nutra's flagship product, ProLon, to clients as part of their cardiometabolic solutions
Together, L-Nutra and Lindora will use the science of Fasting Mimicking Diets (FMD) to help clients at their 31 boutiques improve their metabolic health. (Credit: Louis Hansel on Unsplash)
Lindora, Southern California’s leading weight management and metabolic health practice, announces a partnership with L-Nutra Inc., the premier nutri-technology company spearheading longevity science nutrition programs. Together, L-Nutra and Lindora will use the science of Fasting Mimicking Diets (FMD) to help clients at their 31 boutiques improve their metabolic health.
L-Nutra’s flagship product, Prolon, is a 5-Day guided FMD program that is scientifically proven to induce cellular rejuvenation and improve metabolic function by mimicking the effects of a prolonged water fast while still providing food. Coupled with their on-site, medically guided client care, Lindora will begin offering Prolon as a supplementary program for clients suffering from cardiovascular disease, diabetes, insulin resistance, among other conditions.
“At Lindora, we are dedicated to coaching our clients in all aspects of their metabolic health journey,” said Colleen Lewis, CEO of Lindora. “We are so excited to now have L-Nutra’s data-backed, science-led product as part of our offerings. We are confident that Prolon will help our clients improve their metabolic health scores.”
“Our 7+ years of research studying the effects of Prolon on varying metabolic diseases, specifically diabetes and cardiovascular disease, consistently shows the power of FMD in managing and even reversing metabolic risk factors for these conditions,” said Michael Lawsky, President of L-Nutra Corporate and Chief Corporate Development & Strategy Officer. “L-Nutra is proud to partner with Lindora to help their clients achieve their wellness goals.”
A study published in Science Transitional Medicine shows that those who followed the FMD for three months had reduced body weight, overall body fat, exhibited lowered blood pressure and triglycerides, and had improved blood glucose levels. C-reactive protein, a marker for internal inflammation and an independent risk factor for disease, was also reduced in those following Prolon consistently.
Clients who receive L-Nutra products through Lindora will be offered guidance and supervision through Lindora practitioners.
Source: Company Press Release